RMTI news

Rockwell Medical announced a transformative acquisition of Vantive's hemodialysis assets, adding new manufacturing capabilities and a global customer base to reach annual revenue projections between $400 and $450 million.

Rockwell Medical announced it has regained compliance with Nasdaq's minimum bid price requirement by maintaining $1.00 closing bid prices from July 1 to July 15, 2026. As a result, trading of the company's RMTI shares remains active on the Nasdaq Capital Market.

BDO USA, P.C. confirmed agreement with statements made by Redwood Mortgage Investors VIII regarding an auditor change on May 29, 2026. The filing represents a routine accounting firm transition disclosure required by SEC regulations.